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Providing health care for children is a unique specialty, and pediatric patients represent approximately
25% of the population. Education of pharmacy students on patients across the lifespan is required by
current Accreditation Council for Pharmacy Education standards and outcomes; thus, it is essential that
pharmacy students gain a proficiency in caring for children. A collaborative panel of pediatric faculty
members from schools and colleges of pharmacy was established to review the current literature
regarding pediatric education in Doctor of Pharmacy curricula and establish updated recommendations
for the provision of pediatric pharmacy education. This statement outlines five recommendations
supporting inclusion of pediatric content and skills in Doctor of Pharmacy curricula.
Keywords: pediatric, pharmacy, education

Pediatrics PRN provided a list of 28 pediatric subject
areas for inclusion in core and/or elective curricula and
advised that these pediatric topics be taught by pediatric
content experts whenever possible.1 These recommendations, now more than a decade old, lack discussion on
integration into skills courses and do not account for
more recent pediatric pharmacotherapy and guideline
updates.
The pediatric age group accounts for approximately
one-quarter of the United States population.2 In those
under 18 years of age, overall rates of outpatient health
care visits are increasing and exceed rates in adults aged
19 to 64 years.3 Furthermore, 70% of all visits to pediatric
practices include the mention of a medication,4 a number
that has increased over time. Regarding medication use,
approximately 22% of children in the United States receive a prescription medication each month.3 Pharmacists

INTRODUCTION
In 2005, the Pediatrics Practice and Research Network (PRN) of the American College of Clinical Pharmacy (ACCP) published an opinion paper that provided
recommendations for pediatric content in schools and
colleges of pharmacy in the United States and Canada.1 In
this paper, the Pediatrics PRN recommended that all
pharmacy programs offer a minimum of 25 contact hours
of didactic instruction in pediatrics, that elective courses
in pediatrics are available and provide 16-32 contact
hours, and that all students have access to at least one
pharmacy practice experience in the area of pediatrics. To
guide curricular development and revision, the ACCP
Corresponding Author: Christina L. Cox, University of
South Carolina, College of Pharmacy, 715 Sumter St.,
Columbia, SC. Tel: 803-777-1947. Email: coxcl@cop.sc.edu
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are therefore very likely to encounter pediatric patients in
their daily practice, whether in the inpatient or outpatient
setting.
In addition to contributing significantly to health
care visits and prescriptions, pediatric patients are three
times more likely to experience a medication error than
adult patients.5 This is primarily because of pharmacokinetic differences between children and adults, limited
availability of pediatric-friendly dosage forms, lack of
standardization in dosing and medication concentrations,
inconsistent dosing devices, and calculation errors because of the need for weight-based dosing. These dosing
errors may be due to inaccurate or outdated patient
weights, transcription errors when documenting weights
in a child’s health record, or documentation of incorrect
weight units (ie. kilograms and pounds). A 2015 survey of
community pharmacists found that only 31% reported
checking doses for pediatric prescriptions fairly often,
nearly always, or always.6 Medication safety issues are
compounded by the lack of well-designed studies in
children. Although regulatory changes, including the
2002 Best Pharmaceuticals for Children Act (BPCA),7
the 2003 Pediatric Research Equity Act (PREA),8 the
2012 Food and Drug Administration Safety and Innovation Act (FDASIA),9 and the 2017 Research to Accelerate
Cures and Equity (RACE) for Children Act10 have made
significant strides in protecting children, less than 50% of
medications are labeled for use in children and lack pediatric-specific information, including dosing, efficacy,
and safety.11 Additionally, over the last 15 years, the Food
and Drug Administration (FDA) has received 1200 pediatric studies, and over 700 medication labels have been
changed.12 Because this has potential implications on the
safe and effective use of medications in the pediatric
population, it highlights the importance of ensuring all
pharmacy graduates are competent for entry-level positions in which they will care for pediatric patients. Pharmacy curricula should emphasize each of these unique
aspects of caring for children.
A survey conducted nearly a decade after the publication of the first ACCP Pediatrics PRN opinion paper
demonstrates that there are still opportunities to improve
the preparation of pharmacy graduates to deliver basic
care to pediatric patients.13 The 2013 survey of accredited
and candidate-status US pharmacy programs revealed that
94% of respondents include pediatric topics as part of their
required curricula; however, the median number of contact
hours is 16, well below the 25 hours recommended in the
2005 paper.1,13 Only 61% of pharmacy programs offer a
pediatrics elective; and while 97% of respondents report
offering pediatric advanced pharmacy practice experiences
(APPEs), only 20% of eligible students complete a pediatric

APPE. Additionally, although the survey indicated that
schools have, on average, two full-time and two adjunct
faculty members specializing in pediatrics who can provide
pediatric content or APPEs, only 75% of all programs
employ a full-time pediatric faculty member. This highlights the need to readdress the initial recommendations of
the 2005 opinion paper.

METHODS
Pediatric faculty members of the American Association of Colleges of Pharmacy (AACP) Pediatric Pharmacy
Special Interest Group (SIG), American College of Clinical
Pharmacy (ACCP) Pediatrics Practice and Research Network (PRN), and Pediatric Pharmacy Association (PPA)
recognized the need for collaboration in order to provide
educators with consensus recommendations on pediatric
content and skills in Doctor of Pharmacy (PharmD) curricula. Members from each organization served as the initial
discussion group and guided author selection. Because the
PPA has the largest membership of pediatric pharmacy
practitioners and many of its members are members of at
least one of the other organizations, author recruitment was
conducted electronically through the PPA academic SIG.
Interested contributors were asked to submit their curricula
vitae, which were subsequently reviewed for consideration.
Purposeful selection of authors included that they meet the
following requirements: they were an academician at the
rank of associate professor or professor; were a member in
at least two of the participating organizations; and had a
sustained record of achievement in the area of pediatric
education and/or pharmacy practice. The collaborative
panel included 12 academic members, four from each organization to ensure equal representation. No conflicts of
interest were identified among the authors.
After finalizing and convening the panel, three task
forces were formed to address the major needs of the
project, which included: a literature evaluation pertaining
to pediatric pharmacy and education, current fulfillment of
the Accreditation Council for Pharmacy Education’s
(ACPE) 2016 Standards for the PharmD degree14 by pediatric content, and pediatric pharmacy curricular recommendations. Each task force was comprised of members
representing at least two organizations and met via webbased teleconferences or electronically to ensure full participation without geographical or logistical barriers. The
literature evaluation task force, comprised of six members,
was provided a set list of discussion points compiled by
the panel. Special assignment was considered for authors
having completed work in a respective interest area.
Each member of this task force individually conducted
a PubMed search and submitted published manuscripts,
abstracts, or other relevant position statements to a shared
1062
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electronic repository. Each reference was placed into one
of seven categories: pediatric patient care (general), pediatric education, pharmacy, other health professions, pediatric pharmacy role in patient care, pediatric diseases into
adulthood, or other. Articles were summarized and
reviewed by at least two task force members to ensure
relevance and accuracy.
A task force of three members reviewed the ACPE
Standards 2016 and the Center for the Advancement of
Pharmacy Education (CAPE) Outcomes 2013.14,15 After
compiling a list of elements from the Standards 2016,
each member of the task force individually evaluated the
relevance of each element to pediatric pharmacy practice.
Consensus on the relevance of each element in Standards
2016 was achieved among the members of the task force.
Additional feedback was solicited from the panel, discussed within the task force, and incorporated into the
final list of ACPE Standards 2016 and CAPE outcomes
that relate to pediatric pharmacy practice.
A three-member task force developed an initial list of
pediatric pharmacy topics based on previously published
recommendations and various educational studies.1,16,17
The final list of pediatric pharmacy topics was decided by
unanimous vote between the three members of this task
force. The topic list was then sent to the panel for comment and approval. After comments were received, the
list of pediatric core topics that every graduating pharmacist should be exposed to during their required PharmD
curricula was finalized (Tables 1 and 2). This list was then
stratified into topics that, based on the level of expertise
required, could be covered by either pediatric-trained or
non-pediatric trained faculty members.
Upon completion of the panel-approved recommendations and manuscript draft, an open-comment period was
provided to each organization using Dotstorming, an
online group-sharing and decision-making tool. Members
of the PPA, the ACCP Pediatrics PRN, and the AACP
Pediatric Pharmacy SIG were asked to vote and comment
on each of the five recommendations. Feedback was discussed by the panel and incorporated into the final draft
accordingly. The final recommendations were distributed
to the following for a vote: AACP Pediatric Pharmacy SIG,
ACCP Pediatrics PRN, and PPAG Board of Directors.
Upon approval from each of the groups listed, the joint
statement was submitted for publication. Final recommendations are included in Table 3.

patient population with which they are working. Standard
2 describes "essentials for practice and care," and includes
patient-centered care and population-based care.17 Historically, medications are approved with limited to no
information regarding dosing, safety, or efficacy in pediatric patients; therefore, pharmacy graduates must be
able to interpret patient information and apply available
scientific data to pediatric patient populations to ensure
safe and effective use of medications in children (ACPE
standard 25.7, CAPE outcomes 2.1 and 2.4). Of equal
importance is proficiency in communication with children and their caregivers, including patient education
(ACPE standard 3.6, CAPE outcomes 3.2 and 3.6). The
skills necessary to educate or communicate with a young
child and his/her adult caregiver or an adolescent who is
starting to assume some responsibility for his/her health
care are vastly different but no less important than those
needed to communicate with someone who has a low
health literacy or who does not speak English as their first
language. In addition to meeting ACPE educational outcomes, in 2017 the American Association of Colleges of
Pharmacy published pharmacy-specific EPAs that colleges are expected to incorporate throughout the required
PharmD curriculum.18 The Association of American
Medical Colleges originally outlined EPAs as “units of
professional practice, defined as tasks or responsibilities
that trainees are entrusted to perform unsupervised once
they have attained specific sufficient competence.”19
Entrustable professional activities are subdivided by the
level of supervision required by the student, from level 1
where the student observes a task, through level 5, where
the student is able to teach others. For students to develop
the baseline knowledge, skills, and attitudes necessary to
care for children at an expected EPA competency level,
pediatric education must be intentionally integrated into
didactic and experiential pharmacy curricula.
Didactic Education
The pharmaceutical care needs of patients differ
greatly based on age, from prenatal care through adulthood. This idea of the provision of “care across the lifespan” is central to ACPE Standards 2016. For students to
develop the knowledge and skills necessary for the care of
children, pediatric content must be integrated into all
aspects of the didactic curriculum, including biomedical,
pharmaceutical, clinical, social/administrative/behavioral sciences, and clinical sciences (ACPE Standard 12.4).
Didactic instruction should address changing human
physiology throughout childhood development, common
conditions unique to pediatric patients, calculations pertinent to pediatric medication therapy, and social and
behavioral aspects that influence a child’s health. Tables 1

REVIEW AND RECOMMENDATIONS
All graduates of an accredited pharmacy program
should be able to meet the basic educational outcomes
specified by ACPE at an appropriate entrustable professional activity (EPA) competency level, regardless of the
1063
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Table 1. Recommended Pharmacy Curricula Pediatric Topics to Be Included in the Didactic Portion of the Curricula for the Doctor
of Pharmacy Program
System
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General

Neurology

Psychiatry
Pulmonology
Cardiology
Gastrointestinal and
hepatology

Nephrology

Should Be Taught by
Pediatric-Trained Faculty
Anatomical differences in the pediatric population
(including growth and development, vital signs, etc)
Calculations (Dosing, CrCl, etc)
Communication skills
Medication safety (Prescriptions risks, technology, etc)
Pharmacokinetic/Pharmacodynamic differences
Dosage forms
Drug information sources for pediatrics
Fever
Pediatric seizures (eg, febrile seizures, infantile
spasms)
Ketogenic diet
Attention deficit hyperactivity disorder
Autism spectrum disorder
Cystic fibrosis
Hypertension
Anticoagulation
Pediatric nutrition (enteral and parenteral)
Pediatric specific fluid and electrolyte balance
(including dehydration management)

Drug dosing in renal dysfunction

Endocrine

Hematology and
oncology

Leukemia/Lymphoma

Immunology,
Rickets
rheumatology,
and metabolic diseases
Infectious disease
Upper respiratory tract infection (croup, pharyngitis)
Bronchiolitis
Pneumonia
Otitis media/Externa
Urinary tract infections (including prophylaxis)
Meningitis
Neonatal sepsis
Pediatric immunizations
Self-care

Neonatal, obstetrics,
and reproductive

Cough/Cold/Sore throat
Dermatitis (diaper, etc.)
Eczema
Bronchopulmonary dysplasia and respiratory
distress syndrome
Routine neonatal care (vitamin K, etc.)
Drugs in pregnancy and lactation
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Could Be Taught by Non-Pediatric
Trained Faculty Member
Medication adherence specific to pediatrics
Toxicology/Poison prevention specific to pediatrics
Consent and assent/Research
Pharmacogenomics

Depression
Asthma

Gastroesophageal reflux/Peptic ulcer disease
Nausea/Vomiting
Diarrhea
Constipation
Dose adjustments in liver dysfunction
Acute renal failure
Chronic kidney disease
Type 1 diabetes mellitus
Type 2 diabetes mellitus
Diabetic ketoacidosis and HHNS
SIADH
Thyroid disease
Anemia
Sickle cell disease
Supportive care
Food allergies
Familial hypercholesterolemia
Head lice
Scabies
Pinworm
Cellulitis
Osteomyelitis/Septic arthritis
Sexually transmitted infections
Surgical prophylaxis
Influenza
Endocarditis
Allergic rhinitis
Acne
Skin care (wounds, burns, etc)
Contraception

American Journal of Pharmaceutical Education 2020; 84 (8) Article 7892.
Table 2. Recommended Pharmacy Curricula Pediatric Topics to Be Included in Elective Pharmacy Courses for the Doctor of
Pharmacy Program
System
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Neurology

Psychiatry
Pulmonology
Cardiology

Gastrointestinal and hepatology

Nephrology

Endocrine
Hematology and oncology

Immunology, rheumatology, and metabolic
diseases

Infectious disease

Self-care
Neonatal, obstetrics,
and reproductive

a

Elective Topics
Cerebral palsy
Headache/migrainea
Pain/Sedation
Neonatal Abstinence Syndrome/Drug abusea
Bipolar/Schizophrenia – Pediatric-specific components and monitoringa
Acute respiratory distress syndrome/Acute lung injury
Congenital heart disease/Heart failure
Acquired heart disease (Rheumatic and Kawasaki’s)
Pediatric advanced life support
Pulmonary hypertensiona
Inflammatory bowel diseasea
Appendicitisa
Hyperbilirubinemia
Hepatitisa
Interstitial nephritis
Nephrotic syndrome
Hemolytic uremia
Polycystic kidney disease
Enuresis
Renal tubular acidosisa
Adrenocortical insufficiency
Diabetes insipidus
Hemophilia
Idiopathic thrombocytopenic purpura
Central nervous systemmalignancies
Hodgkin’s and non-Hodgkin’s disease
Neuroblastoma
Osteosarcoma
Disseminated intravascular coagulation
Rhabdomyosarcoma
Juvenile idiopathic arthritis
Systemic lupus erythematosusa
Glycogen storage disease
Other inborn errors of metabolism
Phenylketonuria
Pediatric sepsis/Septic shock
Parasitic infectionsa
Tuberculosisa
Pediatric HIV
Psoriasisa
Retinopathy of prematurity
Intraventricular hemorrhage
Necrotizingenterocolitis
Patent ductusarteriosus
Apnea with bradycardia
Premature labor
Premature rupture of membranes
Pre-eclampsia/Eclampsia
Neonatal abstinence syndrome

May be covered in adult-focused electives or by non-pediatric trained faculty (ID specialists,etc.)

1065

American Journal of Pharmaceutical Education 2020; 84 (8) Article 7892.

Downloaded from http://www.ajpe.org by guest on October 9, 2020. © 2020 American Association of Colleges of Pharmacy

Table 3. Recommendations for Didactic and Experiential Pediatric Pharmacy Curricula for the Doctor of Pharmacy Program
Incorporate basic pediatric content with pediatric focused learning objectives throughout the required curriculum. Pediatric content
should be taught by pediatric-trained faculty or content experts in specific fields of pharmacy. Include 30 to 50 hours of pediatric
content to ensure an adequate level of competency.
Offer an elective course in pediatrics.
Integrate active-learning strategies into the pre-APPE pediatric pharmacy curriculum.
Ensure that each pharmacy graduate completes at least one pediatric focused APPE. When a pediatric APPE is not available, adapt
APPE programs to allow the student to demonstrate competence in applying Level 3 or higher Entrustable Professional
Activities to pediatric patients.
Support concentrations in pediatric pharmacy.

and 2 provide a list of topics recommended for both the
required and elective courses with pediatric subject
matter. The intent of these recommendations is to include
curricular incorporation as stand-alone topics and/or as a
subtopic of primarily adult-focused topics in including,
but not limited to, therapeutics, pharmacy practice laboratory, and/or integrated courses. For pharmacy students
to reach the expected EPA competency level needed for
pediatric patient care, the panel recommends that schools
strive to include approximately 30 to 50 hours in the
curriculum. In the instance that programs have a shortened curriculum, the panel supports investigating innovative ways to incorporate the suggested content.
Pharmacy programs must employ (or contract) pediatric-trained faculty/practitioners to teach pediatric
content in the didactic curriculum (ACPE standard 10.6).
Ideally, pediatric faculty members should have completed a PGY2 residency (or equivalent experience) and
be board certified as a pediatric pharmacy specialist.20
Table 1 includes content that should be taught by pediatric-trained faculty members and content that may be
taught by non-pediatric faculty members. The recommendations consider that there are significant differences
in pathophysiology and pharmacotherapy for pediatric
patients that may be missed if certain topics are covered
only by adult practitioners. For example, many institutions employ faculty members specializing in cardiology,
but pediatric and adolescent hypertension differs in origin, definition, and subsequent treatment options. For
content areas that are similar between adult and pediatric
patients, instruction by non-pediatric trained faculty
members who are experts in a specific area of pharmacy,
such as asthma and diabetes, can occur.
In addition to the required curriculum, ACPEaccredited institutions should offer a pediatrics elective
course, preferably coordinated by pediatric-trained faculty members, to allow students interested in the field to
expand their knowledge beyond those topics taught
within the required curriculum (ACPE standard 10.9).
When selecting topics for a pediatric elective, the course

coordinator should evaluate the school’s mission and
primary goals along with the topics and teaching methodologies in the program’s required and elective curriculum. The content of the elective should include
“required” topics (Table 1) that were not incorporated
into the standard curriculum, and time permitting, may
include supplementary topics listed in Table 2. If the
program has limited faculty members with the necessary
expertise, the coordinator is encouraged to identify pediatric pharmacists or adjunct instructors with pediatric
practice experience within their regions who have the
knowledge and interest. For example, some institutions
use APPE preceptors in elective courses, while others
may contract with pediatric clinicians at a local children’s
hospital to educate students in the elective course.
The ACPE Standards 2016 stipulate that active
learning be emphasized within the pharmacy school
curricula.14Active-learning pedagogies, which include
but are not limited to problem-based learning (PBL),
team-based learning (TBL), case-based instruction, and
simulation-based learning, have been used to compliment
lecture in pharmacy education and other higher education
settings21,22 and have been found to enhance pharmacy
student learning and abilities.23-40 A 2013 survey of pediatric pharmacy education at pharmacy programs in the
United States revealed that, although lecture is heavily
relied on to teach pediatric content, the use of active
learning is common.38 Case-based instruction was the
most common active-learning pedagogy used (88%), with
TBL (34%), PBL (30%), and simulation (10%) used more
sparingly.
All pharmacy students are expected to apply clinical
reasoning skills to patients of any age, and these skills
should be assessed regularly throughout the curriculum
(ACPE Standard 25.7). The integration of an activelearning pedagogy into pharmacy curricula to teach pediatric content may help accomplish this by providing
students the opportunity to apply what they have learned
and to develop the key attitudes and skills necessary to
critically think through therapeutic and pharmaceutical
1066
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care issues in the pediatric population. The inclusion of
active-learning can be accomplished in a variety of ways,
including but not limited to, pharmaceutical care laboratories focused on pediatric friendly dosage forms, administration techniques/dosing of medications to pediatric
patients, nonprescription medication use in children, and
effective communications skills when working with a child
and his/her caregiver. However, because active learning
may require a larger time commitment than other pedagogical approaches, strategic consideration must be
given to its incorporation into the curriculum. All pharmacy programs should use some degree of active
learning to teach pediatric topics in the curricula to
enhance student learning. This can be accomplished
through the following: integration of active-learning
pedagogy into the didactic curriculum; provision of one
or more immersive co-curricular activities focused on
pediatrics within introductory pharmacy practice experiences (IPPEs); provision of one or more simulationbased learning exercises focusing on pediatrics prior to
advancement to APPEs; or integration of one or more
pediatric-focused objective structured clinical examinations
(OSCEs) to provide a means to assess students’ clinical
reasoning skills in the area of pediatric pharmacy.

(1) identify rotation experiences that are not pediatricfocused but do include provision of care to pediatric patients (eg, emergency departments, family medicine
clinics); (2) consider a “co-preceptor” model that includes
interprofessional education and use of faculty members or
adjunct faculty members to provide basic tenants (eg, the
student accompanies a pediatric hospitalist on daily
rounds and meets with a pharmacy faculty member on a
daily basis to discuss pediatric patients and topics); (3)
develop and maintain a pediatric reference library for use
by students during APPEs, regardless of the type of rotation experience. For pharmacy schools where there is a
limited availability of pediatric-focused APPEs, this
panel recommends that students should have, at minimum, the opportunity to achieve level 3 EPAs for a pediatric patient in each of the following domains: patient
care provider, interprofessional team member, population
health promoter, information master, and practice manager. As a baseline requirement, students shall be able to
demonstrate level 3 competency in fulfilling a pediatric
medication order as outlined in the practice manager
domain. Table 4 offers an example of incorporating both
low- and high-level EPAs in pediatric care, which can be
used in each of the three solutions mentioned above.

Experiential Education
Enhanced pre-APPE pediatric curricular content
affords students the opportunity to build a solid foundation to achieve both specialized competencies and milestone EPAs. Both IPPEs and APPEs have long been
established as integral components of the curriculum and
now serve as practical opportunities for students to
meet all levels of EPAs. However, it is imperative that
these EPAs include pediatric competencies for all pharmacy graduates. Pharmacy programs should offer IPPEs
and APPEs structured to allow exposure to pediatric patients, among other diverse populations (ACPE Standard
10.9 and 13.2), through which students will advance from
level 1 activities to level 3 by graduation.
To elevate pediatric pharmacy education and the
level of EPAs, the panel strongly recommends that each
PharmD student complete at least one pediatric-focused
APPE. This recommendation is consistent with the recommendations of the previous working group.1 In a survey of US pharmacy programs, IPPEs and APPEs in
pediatrics are offered by 53% and 97% of institutions,
respectively. Even though many programs have pediatricfocused rotation experiences available, only 20% of
PharmD students completed at least one, most likely
the consequence of an insufficient supply of these APPEs
at most pharmacy schools.13 When no pediatric-focused
APPEs are available, the following are potential solutions:

Pediatric Pharmacy Concentrations
With the expansion of pharmacy practice opportunities across the United States, several pharmacy programs have developed curricular tracks for students to
focus on a specific pharmacy practice area.41-43 The goal
of these tracks may vary among pharmacy programs, but
in general, the intention is to prepare students for postgraduate opportunities (eg, residency and fellowship) and
board certification, provide exposure to clinical research,
and offer a concentrated experience in a specific patient
care area. As mentioned previously, students receive a
median of 16 hours of pediatric content in their pharmacy
curricula, and only 20% of students complete a pediatric
APPE.38 Based on these data, graduates of pharmacy
programs who have an interest in pediatrics may not be
prepared for entry-level positions in children’s hospitals
and a curricular track in pediatrics offers a mechanism
for exposing students to core competencies required of
clinical pharmacists caring for this vulnerable population.44-49
A few pharmacy programs have developed pediatric
curricular tracks.49,50 Pediatric curricular tracks provide
students with depth of training in pediatrics, generally
offering opportunities for students to complete at least one
didactic elective in pediatric pharmacy, an independent
study involving pediatric research, and at least one pediatric
APPE.50 The clinical knowledge and problem-solving
1067

American Journal of Pharmaceutical Education 2020; 84 (8) Article 7892.
Table 4. Example Progression of Entrustable Professional Activities for Pediatric Immunizations for the Doctor of Pharmacy
Program
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Core Entrustable
Professional Activities
(Patient Care Provider
Domain)

Pediatric
Immunizations

Collect information to identify
a patient’s medicationrelated problems and
health-related needs

Properly assess
immunization
history

Establish patient-centered
goals and create a care
plan for a patient in
collaboration with the
patient, caregiver(s), and
other health professionals
that is evidence-based and
cost-effective
Implement a care plan in
collaboration with the
patient
Follow-up and monitor a
care plan

Interpret the CDCa
vaccination schedule
and provide
recommendations
based on age and
history

a

IPPE

APPE

Observe a pharmacist obtaining
a vaccination history for a
pediatric patient from a
caregiver and/or an online
vaccine registry (Level 1) and
then doing the same with
supervision (Level 2)
Identify the CDC vaccination
schedule for children and
determine which vaccines the
child needs (Level 1-2)

Interview the caregiver and/or
patient to determine if any
contraindications to vaccination
exist (allergies, etc.) (Level 3 or
higher?)

Recommend which vaccines the
child should receive and
determine the appropriate route,
needle size, and administration
site (Level 3 or higher)

Administer
vaccinations

Where allowed by state law, administer vaccinations to a child under the
supervision of a licensed pharmacist (Level 4-5)

Monitor the patient for
adverse reactions to
vaccines; Develop
plan for follow-up
vaccines

Determine what monitoring
parameters are appropriate for
the immunizations that are
being administered; Determine
when follow-up vaccines (eg,
booster doses) should be
administered (Level 1-2)

Monitor the patient for applicable
adverse reactions and counsel
the patient and caregiver on any
potential adverse reactions;
Communicate follow-up plan
and rationale to caregiver and/
or healthcare provider (Level 4-5)

CDC5Centers for Disease Control

skills gained in caring for a pediatric patient through
these curricular tracks can be applied to a variety of
practice settings in the community or health-system
setting and are not limited to students seeking pediatric
clinical specialist positions. Two programs that have
a pediatric curricular track found that 40%-66.7% of
PharmD graduates who chose the track went on to
complete a PGY1 residency at an institution that specialized in pediatrics or that offered several pediatric
rotations.50,51 Although pharmacy programs may find
development and maintenance of concentrations difficult because of limited faculty time and resources,
curricular tracks may better prepare students for postgraduate training and pediatric board certification or
may better qualify and equip them for entry-level positions in children’s hospitals.

and application of limited pediatric information despite
continued drug discovery and innovation. To ensure
provision of safe and effective care to this special population, it is important for schools and colleges of pharmacy to make certain that all pharmacy graduates are
competent for entry-level positions in which they will
care for pediatric patients, whether that is in residency
training, a small community hospital, or a community
pharmacy. Future accreditation standards can assist in
incorporating these pediatric competencies.
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CONCLUSION
Pharmacy education must account for care across the
lifespan, increased medication safety risks in pediatrics,
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